REGISTERED NUMBER: 13695177 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 December 2024

for

HOCL HEALTH LIMITED

Page

Company Information

1

Chartered Accountants' Report

2

Balance Sheet

3

Notes to the Financial Statements

4

DIRECTORS:

D J Aris

N B Ker

R Wells

REGISTERED OFFICE:

26 Pantglas Industrial Estate

Bedwas

Caerphilly

CF83 8DR

REGISTERED NUMBER:

13695177 (England and Wales)

ACCOUNTANTS:

Richardson Swift

Chartered Accountants

11 Laura Place

Bath

BA2 4BL

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of HOCL Health Limited for the year ended 31 December 2024 which comprise the Income Statement, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of HOCL Health Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of HOCL Health Limited and state those matters that we have agreed to state to the Board of Directors of HOCL Health Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than HOCL Health Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that HOCL Health Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of HOCL Health Limited. You consider that HOCL Health Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of HOCL Health Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Richardson Swift

Chartered Accountants

11 Laura Place

Bath

BA2 4BL

30 September 2025

FIXED ASSETS

Intangible assets

4

4,502

-

Tangible assets

5

71,825

725

76,327

725

CURRENT ASSETS

Stocks

13,285

32,909

Debtors

6

45,340

10,003

Cash at bank

10,057

9,798

68,682

52,710

CREDITORS

Amounts falling due within one year

7

214,115

179,982

NET CURRENT LIABILITIES

(145,433

)

(127,272

)

TOTAL ASSETS LESS CURRENT LIABILITIES

(69,106

)

(126,547

)

CAPITAL AND RESERVES

Called up share capital

8

164,786

3

Retained earnings

(233,892

)

(126,550

)

(69,106

)

(126,547

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 September 2025 and were signed on its behalf by:

N B Ker - Director

1.	STATUTORY INFORMATION

HOCL Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The directors have prepared the financial statements on a going concern basis despite the deficit on the balance sheet in the belief that, with the support of the company's shareholders and directors, the company is in a position to continue trading.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover is recognised when the sale is made.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of four years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Office Equipment

-

33% on cost

Plant and Equipment

-

25% on cost

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Financial instruments

The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other debtors, loans from banks and other third parties.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the profit or loss.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate determined under the contract.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and the best estimate, which is an approximation, of the amount the company would receive for the asset if it were to be sold at the reporting date.

Financial assets and liabilities are offset and the net amount reported in the balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Critical accounting estimates and uncertainties

No significant judgements or key assumptions have had to be made by directors in preparing these financial statements.

Hire purchase and leasing agreements

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2023 - 4 ) .

4.	INTANGIBLE FIXED ASSETS

Patents

and

licences

£

COST

Additions

4,855

At 31 December 2024

4,855

AMORTISATION

Amortisation for year

353

At 31 December 2024

353

NET BOOK VALUE

At 31 December 2024

4,502

5.	TANGIBLE FIXED ASSETS

Office

Plant and

Equipment

Equipment

Totals

£

£

£

COST

At 1 January 2024

1,088

-

1,088

Additions

-

78,870

78,870

At 31 December 2024

1,088

78,870

79,958

DEPRECIATION

At 1 January 2024

363

-

363

Charge for year

362

7,408

7,770

At 31 December 2024

725

7,408

8,133

NET BOOK VALUE

At 31 December 2024

363

71,462

71,825

At 31 December 2023

725

-

725

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Trade debtors

36,636

1,829

Other debtors

8,704

8,174

45,340

10,003

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Trade creditors

87,856

28,948

Amounts owed to group undertakings

55,500

-

Taxation and social security

407

301

Other creditors

70,352

150,733

214,115

179,982

8.	CALLED UP SHARE CAPITAL

Alloted, issued and fully paid

Nominal

2024

2023

Number:

Class:

Value:

£

£

0

Ordinary

£1

0

3

126,524

A Ordinary

£1

126,524

0

28,262

B Ordinary

£1

28,262

0

10,000

C Ordinary

£1

10,000

0

164,786

3

During the year, 3 £1 ordinary shares were reclassified into 2 £1 A ordinary shares and 1 £1 B ordinary shares.

An additional 164,783 shares were issued during the year. 126,522 A ordinary shares, 28,261 B ordinary shares and 10,000 C ordinary share all at the nominal value of £1 per share.